- Home
- JL vs EVAX Comparison
JL vs EVAX Comparison
Compare JL & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JL
- EVAX
- Stock Information
- Founded
- JL 1985
- EVAX 2008
- Country
- JL Hong Kong
- EVAX Denmark
- Employees
- JL N/A
- EVAX N/A
- Industry
- JL
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JL
- EVAX Health Care
- Exchange
- JL NYSE
- EVAX Nasdaq
- Market Cap
- JL 10.0M
- EVAX 10.8M
- IPO Year
- JL 2024
- EVAX 2021
- Fundamental
- Price
- JL $5.32
- EVAX $3.13
- Analyst Decision
- JL
- EVAX Strong Buy
- Analyst Count
- JL 0
- EVAX 2
- Target Price
- JL N/A
- EVAX $10.00
- AVG Volume (30 Days)
- JL 23.1K
- EVAX 135.1K
- Earning Date
- JL 07-31-2025
- EVAX 05-27-2025
- Dividend Yield
- JL N/A
- EVAX N/A
- EPS Growth
- JL N/A
- EVAX N/A
- EPS
- JL 0.54
- EVAX N/A
- Revenue
- JL $32,831,195.00
- EVAX $3,293,000.00
- Revenue This Year
- JL N/A
- EVAX N/A
- Revenue Next Year
- JL N/A
- EVAX N/A
- P/E Ratio
- JL $9.84
- EVAX N/A
- Revenue Growth
- JL 7.72
- EVAX 2555.64
- 52 Week Low
- JL $2.33
- EVAX $1.20
- 52 Week High
- JL $13.41
- EVAX $19.95
- Technical
- Relative Strength Index (RSI)
- JL 70.32
- EVAX 75.25
- Support Level
- JL $5.23
- EVAX $2.58
- Resistance Level
- JL $5.47
- EVAX $2.84
- Average True Range (ATR)
- JL 0.35
- EVAX 0.25
- MACD
- JL 0.03
- EVAX 0.10
- Stochastic Oscillator
- JL 70.28
- EVAX 96.79
About JL J-LONG GROUP LIMITED
J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.